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Introduction. Incidence of dilated cardiomyopathy (DCM) 
in children is 0.57/100,000 / year. The management of 
pediatric DCM is not similar to adults, the results of the 
combination of beta-blockers (BB) in the behavior of 
children with DCM is controversial.
Purpose. The effects of beta-blockers (BB) in the clinical-
hemodynamic evolution of children with DCM.
Material and methods. The prospective analytical study 
included 48 children (age 3 months-18 years) with DCM, 
based on anamnestic criteria, clinical and imaging criteria, 
especially echocardiography (Echo) Depending on the 
treatment, the patients were divided into 2 groups: I -14 
children, conventional and BB; II - 34 children -
conventional treatment. 
Results. Most of the children were young (58%), with a
predominance of boys (M F-30/18),with heart failure (HF) II-IV
NYHA/Ross. Echo parameters with non-perforable predictive
value: Tei index, associated with ejection fraction, size of left
ventricle (LVEF, IVS thickness), PAPs and mitral regurgitation
(grade of IVM). We have noticed an unfavorable evolution in 6
children, including 4 deaths, of which 3 (8.82%) cases in group II
(without BB) (Table 1, fig 1).
Conclusions. The Tei index is a predictor of death, 
depending on age and heart failure. The association of BB 
in the treatment of DCM in children in the early stages 
contributes to the clinical and functional improvement of 
the heart. Adverse effects are rare, requiring correct dose 
titration.


























- 0,99 0,99 -0,52 -0,39 0,91 0,89 0,73 0,25 0,22
Weight, kg 0,99 - 0,99 -0,51 -0,38 0,92 0,89 0,70 0,23 0,16
Height,  m 0,99 0,99 - -0,47 -0,37 0,89 0,85 0,72 0,27 0,15
LVEF,% -0,52 -0,51 -0,47 - 0,94 -0,71 -0,74 -0,52 -0,36 -0,87
LFSF% -0,39 -0,38 -0,37 0,94 - -0,57 -0,59 -0,45 -0,39 -0,39
LVDD
mm
0,91 0,92 0,89 -0,71 -0,57 - 0,97 0,60 0,26 0,20
LVSD
mm
0,89 0,89 0,85 -0,74 -0,59 0,97 - 0,60 0,22 0,28
IVS mm 0,73 0,70 0,72 -0,52 -0,45 0,60 0,60 - 0,22 0,70
PAPs
mmHg
0,25 0,23 0,27 -0,36 -0,39 0,26 0,22 0,22 - 0,76
LVTI 0,22 0,16 0,15 -0,87 -0,39 0,20 0,28 0,70 0,76 -
Table1. Associative correlations of EcoCG parameters
in group I patients (p <, 01)
Fig.1. Associative links of the value of 
the IT index and the risk of death
